February 15, 2012 13:45 ET

Point of Care Diagnostic Testing World Market to Jump to $15.9 Billion by 2018

NEW YORK, NY--(Marketwire - Feb 15, 2012) - cites in its newly published "Point of Care Diagnostic Testing World Markets" report that the point of care diagnostic testing world market will jump to $15.9 billion by 2018. For more information, visit:

Point of care diagnostic testing can be categorized into ten main modalities: blood glucose monitoring, blood gas and electrolytes, rapid coagulation, rapid cardiac markers, substance abuse, infectious diseases, urine strip tests, pregnancy tests, fecal occult testing and cholesterol. The U.S. is recognized as the largest single market for point of care testing products, valued at $3.45 billion in 2011. The U.S. point of care market sub-segment represents an estimated 18.6% of the total U.S. market for in vitro diagnostic (IVD) goods and services.

The "Point of Care Diagnostic Testing World Markets" report covers:

  • B-Type Natriuretic Peptide (BNP)
  • Whole-Blood Lactate
  • Creatinine
  • D-Dimer Testing
  • C-Reactive Protein (CRP)
  • Glucose Urine Testing
  • Fertility Testing
  • HIV Testing
  • Alcohol Testing
  • Substance Abuse Testing

The "Point of Care Diagnostic Testing World Markets" report examines companies manufacturing point of care diagnostic testing equipment and supplies in the world. Companies covered include: Abaxis, Abbott, Accumetrics, AccuTech, ACON, Acrongenomics, AgaMatrix, Alere, Alfa, Ani, Ark, Arkray, Atonomics, Audit, Augurix, Axis-Shield, Axxin, Bayer Corp., Beckman Coulter, BioLytical, Biomerica, bioMerieux, BiOracle, Bio-Rad, BioScan, BioSite, Calmark, Calypte, Chembio, Chempaq, Cholestech, Claros, CompuCyte, Concateno, Diagnostics, Dexcom, Enigma, EY, Eurotrol, Exalenz, GenBio, Genzyme, Helena, Hema, HemoCue, HemoSense, Instrumentation Laboratory, International Technidyne, Johnson & Johnson (LifeScan), LifeAssays, LifeSign, Medica, Medical Automation, Mediwatch, Medix, MedMira, MELA, A. Menarini, Meretek, Meridian, Micronics, Minimed, Mitsubishi, New Horizons, Nexus DX/ITC, Nova Biomedical, OraSure, Polymedco, Polymer, Prima, QBC, Qualigen, Quest, Quidel, Radiometer, Response, Roche, Savyon, Selfcare, Shionogi, Siemens Healthcare Diagostnics, Guided, Spectral, StatSure, Strategic, Trinity and Vasamed.

Detailed charts with sales forecasts and marketshare data are included. For more information, visit:

About is a global leader in the biotechnology, healthcare and life sciences market research publishing. For more information, please visit

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.

Contact Information